{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:37:23Z","timestamp":1773081443679,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.hrthm.2006.06.035","type":"journal-article","created":{"date-parts":[[2006,7,9]],"date-time":"2006-07-09T11:06:52Z","timestamp":1152443212000},"page":"1321-1331","source":"Crossref","is-referenced-by-count":47,"title":["Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009"],"prefix":"10.1016","volume":"3","author":[{"given":"Harry J.","family":"Crijns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle C.","family":"Van Gelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e5kan","family":"Walfridsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Kulakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alad\u00e1r","family":"R\u00f3nasz\u00e9ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vratislav","family":"Dedek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Malm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olle","family":"Almgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2006.06.035_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/hrt.71.1.92","article-title":"Treatment of atrial fibrillation in a district general hospital","volume":"71","author":"Lip","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.hrthm.2006.06.035_bib2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.06.035_bib3","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0735-1097(00)00886-X","article-title":"The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy","volume":"36","author":"Dorian","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.06.035_bib4","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/archinte.160.12.1749","article-title":"Quality of life in patients with atrial fibrillation","volume":"160","author":"Luderitz","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2006.06.035_bib5","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults","volume":"285","author":"Go","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.hrthm.2006.06.035_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0735-1097(03)00577-1","article-title":"Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study","volume":"42","author":"Pappone","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.06.035_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jacc.2003.08.037","article-title":"Effect of rate or rhythm control on quality of life in persistent atrial fibrillation","volume":"43","author":"Hagens","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.06.035_bib8","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","article-title":"American College of Cardiology\/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation); North American Society of Pacing and Electrophysiology","volume":"104","author":"Fuster","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.06.035_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005344-199709000-00015","article-title":"Clinical and electrophysiologic effects of dofetilide in patients with supraventricular tachyarrhythmias","volume":"30","author":"Kobayashi","year":"1997","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.hrthm.2006.06.035_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1009866126492","article-title":"Frequency-dependent electrophysiological effect of ibutilide on human atrium and ventricle","volume":"5","author":"Oshikawa","year":"2001","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2006.06.035_bib11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00005344-199510000-00005","article-title":"Selective IK blocker almokalant exhibits class III-specific effects on the repolarization and refractoriness of the human heart: a study of healthy volunteers using right ventricular monophasic action potential recordings","volume":"26","author":"Darp\u00f6","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.hrthm.2006.06.035_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1540-8167.2004.03534.x","article-title":"Drug-induced torsades de pointes and implications for drug development","volume":"15","author":"Fenichel","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2006.06.035_bib13","first-page":"S159","article-title":"AZD7009\u2014a new atrial antifibrillatory compound that markedly delays atrial refractoriness in the anaesthetised dog","volume":"1","author":"Duker","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2006.06.035_bib14","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1046\/j.1540-8167.2004.04354.x","article-title":"AZD7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model","volume":"15","author":"Goldstein","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2006.06.035_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1540-8167.2005.40427.x","article-title":"Blocking characteristics of hERG, hNav1.5 and hKvLQT1\/hminK after administration of the novel antiarrhythmic compound AZD7009","volume":"16","author":"Persson","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"Suppl 1","key":"10.1016\/j.hrthm.2006.06.035_bib16","first-page":"506","article-title":"Predominant effects on atrial versus ventricular refractoriness in man by the novel antiarrhythmic agent AZD7009","volume":"26","author":"Edvardsson","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2006.06.035_bib17","series-title":"Guidance for industry: E14 Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs","year":"2005"},{"key":"10.1016\/j.hrthm.2006.06.035_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0735-1097(96)00121-0","article-title":"Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study","volume":"28","author":"Ellenbogen","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.06.035_bib19","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0002-9149(98)00223-9","article-title":"Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation","volume":"81","author":"Reisinger","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2006.06.035_bib20","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1378\/chest.117.6.1538","article-title":"Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study","volume":"117","author":"Vardas","year":"2000","journal-title":"Chest"},{"issue":"Abstract Suppl","key":"10.1016\/j.hrthm.2006.06.035_bib21","first-page":"506","article-title":"Efficacy and safety of RSD1235 in the treatment of recent onset atrial fibrillation in ACT I (Atrial arrhythmia Conversion Trial I), a phase III, randomised, placebo-controlled, multi-center trial","volume":"26","author":"Pratt","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2006.06.035_bib22","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1540-8167.2005.40720.x","article-title":"Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes","volume":"8","author":"Wu","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2006.06.035_bib23","first-page":"1076","article-title":"Attenuation of proarrhythmias related to delayed repolarization by low-dose lidocaine in the anesthetized rabbit","volume":"267","author":"Carlsson","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.hrthm.2006.06.035_bib24","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/01.CIR.96.6.2038","article-title":"Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome","volume":"96","author":"Shimizu","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.06.035_bib25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1365-2362.2001.00849.x","article-title":"Tpeak-Tend interval as an index of transmural dispersion of repolarization","volume":"31","author":"Antzelevitch","year":"2001","journal-title":"Eur J Clin Invest"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527106017310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527106017310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T23:02:47Z","timestamp":1555714967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527106017310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1547527106017310"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2006.06.035","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}